4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001209191-21-063523
Chief Financial Officer bought 3,000 shares at $3.40 ($10,200)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Freve Jonathan Chief Financial Officer | 2021-11-08 | Purchase | +3,000 | $3.40 | $10,200 | 8,000 | D |
| Open-market purchases · 3,000 sh · avg $3.40 · $10,200 | |||||||
Loading xslF345X03/doc4.xml…